ArticleCancer management and research2024

SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer.

Lvwen Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.